Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Low Dose Aspirin for the Prevention of Postpartum Related Breast CancerRecruiting
NCT05557877Phase 2Updated Aug 20, 2026
Sponsor: Mayo Clinic
Breast Carcinoma
United States
A Digital Exercise Intervention in Patients With SpondyloarthritisRecruiting
NCT06462937NAUpdated Aug 20, 2026
Sponsor: Diakonhjemmet Hospital
Spondyloarthritis · Exercise
Norway
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerRecruiting
NCT06058377Phase 3Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · HER2-Negative Breast Carcinoma · Hormone Receptor-Positive Breast Carcinoma
United States, Puerto Rico
Top-Down Attentional Control of Visual-ProcessingRecruiting
NCT01087281N/AUpdated Aug 20, 2026
Sponsor: National Institute of Mental Health (NIMH)
Focal Brain Lesion · Focal Lesions · fMRI
United States
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart FailureRecruiting
NCT07232030NAUpdated Aug 20, 2026
Sponsor: CVRx, Inc.
Heart Failure · Heart Failure NYHA Class II · Heart Failure NYHA Class III
United States
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for ObesityRecruiting
NCT07776678N/AUpdated Aug 20, 2026
Sponsor: Foundation for the National Institutes of Health
Obesity & Overweight
United States
SuperSaturated Oxygen Comprehensive Observational RegistryRecruiting
NCT06438315N/AUpdated Aug 20, 2026
Sponsor: TherOx
STEMI - ST Elevation Myocardial Infarction · AMI
United States
Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary DiseaseRecruiting
NCT06531798Phase 4Updated Aug 20, 2026
Sponsor: AstraZeneca
Moderate to Severe COPD
India
Evaluation of the Efficacy and Safety of Local Cryotherapy Treatment of Recurrent Head and Neck Cancer in Irradiated Areas: a Pilot StudyRecruiting
NCT05738187NAUpdated Aug 20, 2026
Sponsor: University Hospital, Strasbourg, France
Recurrent Head and Neck Cancer · Local Cryotherapy Treatment
France
Creation of a Pre-operative Score, the HASS Score, for Injuries Reliable Diagnosis of Long Biceps TendonRecruiting
NCT06446336N/AUpdated Aug 20, 2026
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche
Biceps Tendon Disorder
France
French Parkinson's Disease Cohort - NS-PARKRecruiting
NCT04888364N/AUpdated Aug 20, 2026
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Parkinson Disease
France
Endogenous Energy Production in Critically Ill PatientsRecruiting
NCT07059988NAUpdated Aug 20, 2026
Sponsor: Karolinska University Hospital
Critical Illness · Metabolism and Nutrition Disorder
Sweden
Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell LymphomaRecruiting
NCT06045247Phase 2Updated Aug 20, 2026
Sponsor: M.D. Anderson Cancer Center
Large B-cell Lymphoma
United States
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell CarcinomaRecruiting
NCT07281417Phase 2Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Sinonasal Squamous Cell Carcinoma · Stage III Sinonasal Cancer AJCC v8 · Stage IVA Sinonasal Cancer AJCC v8 · Stage IVB Sinonasal Cancer AJCC v8
United States
Phase Ⅰ/Ⅱa Trial Evaluating Intravenous hUC-MSCs Injection for Safety, Tolerability and Efficacy in Patients With POIRecruiting
NCT07775391Phase 1, Phase 2Updated Aug 20, 2026
Sponsor: Shenzhen Wingor Biotechnology Co., Ltd.
Premature Ovarian Insufficiency
China
Heart Rate Variability and Anxiety as Predictors of Emergence Agitation After SeptorhinoplastyRecruiting
NCT07389135N/AUpdated Aug 20, 2026
Sponsor: Konya City Hospital
Emergence Agitation · Heart Rate Variability (HRV) · Septorhinoplasty
Turkey (Türkiye)
A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple SclerosisRecruiting
NCT07776743Phase 2Updated Aug 20, 2026
Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD.
Relapsing-remitting Multiple Sclerosis (RRMS)
China
Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1)Recruiting
NCT07776626Phase 1Updated Aug 20, 2026
Sponsor: YolTech Therapeutics Co., Ltd
Primary Hyperoxaluria Type 1 · PH1
China
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)Recruiting
NCT07101432Phase 1Updated Aug 20, 2026
Sponsor: M.D. Anderson Cancer Center
Head and Neck Cancer
United States
Magnesium Sulphate With Atropine and Pralidoxime vs Standard Therapy Alone in Acute Organophosphate PoisoningRecruiting
NCT07777835NAUpdated Aug 20, 2026
Sponsor: Muhammad Aamir Latif
Organophosphate Poisoning
Pakistan
Investigating the Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on the Brain in People With FibromyalgiaRecruiting
NCT07260864NAUpdated Aug 20, 2026
Sponsor: University of Rochester
Fibromyalgia (FM)
United States
Perception, Sensation, Cognition and Action in HumansRecruiting
NCT03407066N/AUpdated Aug 20, 2026
Sponsor: National Eye Institute (NEI)
Normal Physiology
United States
Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology PatientsRecruiting
NCT07776704NAUpdated Aug 20, 2026
Sponsor: Fox Chase Cancer Center
Malnutitrion · Cancer
United States
Real-life Study on the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Multiple MyelomaRecruiting
NCT07777406N/AUpdated Aug 20, 2026
Sponsor: Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Plasma Cell Neoplasms
Italy
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET TrialRecruiting
NCT05327010Phase 2Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm · Unresectable Malignant Solid Neoplasm
United States

Previous page Next page